SweetBunFactory Eagle Pharmaceuticals ( NASDAQ: EGRX ) said on Tuesday that it received a notice on 21st August from the listing department of the Nasdaq Stock Market stating that the company’s failure to timely file its quarterly report serves as a basis for delisting. The company said it is working to prepare and file the delayed reports with the SEC by applicable dates to regain compliance with Nasdaq listing standards. EGRX fell 2.
10% in extended trading on Tuesday. More on Eagle Pharmaceuticals Financial information for Eagle Pharmaceuticals.
